Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2119913
PubMed Identifier: 35857660
Publication URI: http://europepmc.org/abstract/MED/35857660
Type: Journal Article/Review
Volume: 387
Parent Publication: The New England journal of medicine
Issue: 3
ISSN: 0028-4793